CLCassandre Landes-Chateau

Cassandre Landes-Chateau

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Cassandre Landes-Chateau has a total of 51 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Subclinical Optic Nerve Involvement in Radiologically Isolated Syndrome: Multimodal Detection and Diagnostic Impact

    by Christine Lebrun‐Frenay, Cassandre Landes‐Château, Lydiane Mondot, Mikael Cohen, Margherita Popolo, Jérôme de Seze, Bertrand Bourre, Françoise Durand‐Dubief, Olivier Casez, Orhun H. Kantarci, et al.

    Objectives: We aimed to determine the frequency of subclinical optic nerve (ON) lesions using MRI, optical coherence tomography (OCT), and visual evoked potentials (VEP) in radiologically isolated syndrome (RIS), and to assess their diagnostic and prognostic significance. Methods: We conducted a retrospective, multicenter study of 179 RIS individuals followed in clinical practice who met the 2023 RISC criteria. The diagnostic performance of the 2024 McDonald criteria, with and without optic nerve assessment, was evaluated and compared with that of the 2017 criteria. Associations with clinical conversion, comorbidities, and MRI disease activity were analyzed using multivariate models. Results: Silent ON lesions appeared in 107/179 (59.8%) individuals, mainly detected by VEP (100/164; 61.0%) and OCT (69/118; 58.5%), with routine MRI identifying 31/166 (18.7%). During follow‐up, 71 (39.7%) had a first clinical event. The presence, laterality, or number of silent ON lesions did not correlate with clinical conversion, event type, or MRI activity. Younger age and the absence of comorbidities associated with other MRI lesions, rather than with ON lesions, were associated with clinical conversion. Including ON in the 2024 McDonald criteria increased sensitivity but decreased specificity, with 17/179 (9.5%) meeting dissemination‐in‐space criteria solely due to ON lesions. Interpretation: Subclinical ON lesions are common in RIS and are mainly found by OCT and VEP, not routine MRI. Including ON increases sensitivity but does not predict clinical conversion and may lower specificity. These findings suggest cautious interpretation of ON and support a multimodal assessment approach in RIS.


  • Identification et caractérisation de marqueurs prédictifs d'inflammation et de neurodégénérescence chez les personnes présentant un syndrome radiologique isolé

    by Cassandre Landes-Chateau

    Le Syndrome Radiologique Isolé (RIS pour Radiologically Isolated Syndrome) représente la phase pré-clinique de la sclérose en plaques (SEP), et correspond à la découverte fortuite d'anomalies de la substance blanche évocatrices de SEP de par leur localisation, leur taille et leur forme, sur une Imagerie par Résonance Magnétique (IRM) pratiquée pour une autre raison que pour une suspicion de maladie démyélinisante chez des sujets sans histoire de symptôme neurologique et présentant un examen clinique neurologique strictement normal. Les critères diagnostiques de RIS ont été décrits la première fois en 2009 et révisés en 2023 augmentant la sensibilité des critères mais aussi les risques d'erreurs de diagnostic. Ce constat a été à l'origine du premier travail de cette thèse portant sur une enquête française d'identification des lésions de la substance blanche en IRM montrant que de nombreux praticiens utilisent les critères de diagnostic de la SEP même si les anomalies de la substance blanche ne correspondent pas à des lésions démyélinisantes, pouvant engendrer des erreurs dans l'application des critères de diagnostic de SEP. Ces résultats soulignent l'importance d'avoir des marqueurs diagnostiques dans la pratique courante.La seconde étude de cette thèse porte sur l'évaluation d'un marqueur diagnostic appelé « signe de la veine centrale » (SVC) dans le diagnostic de RIS. En effet, des études récentes utilisant l'IRM à haute résolution et notamment une séquence spécifique en IRM de susceptibilité magnétique, la SWI (Susceptibility-Weighted Imaging), permet de mettre en évidence ce SVC. L'IRM obligatoire pour le diagnostic et du suivi du RIS, l'identification de marqueur diagnostic comme le SVC permet d'augmenter la spécificité et la sensibilité du diagnostic et de réduire les erreurs diagnostiques. Une fois le diagnostic de RIS certain et établi, l'identification de marqueurs prédictifs de conversion clinique en SEP constitue un enjeu crucial pour les patients RIS.Le troisième objectif de cette thèse porte sur l'étude du volume des plexus choroïdes dans une large cohorte de patients RIS en comparaison avec des sujets sains afin d'explorer sa relation avec d'autres volumes cérébraux, mais aussi l'activité clinique et radiologique de la maladie et avec des marqueurs biologiques identifiés en parallèle dans notre équipe.La prochaine étape de ce travail sera d'introduire une analyse de biomarqueurs digitaux. En effet, nous avons démontré que des sujets RIS montrent de moins bonnes performances que des sujets contrôles à la passation de tests digitaux à partir de l'utilisation d'applications mobiles. Nous émettons l'hypothèse que des mesures digitales, collectées de façon simple à l'aide d'un smart phone ou d'une tablette, permettraient de déceler des anomalies infracliniques qui témoigneraient d'une évolution silencieuse de la maladie et seraient prédictives d'une évolution clinique.Ce projet de thèse porte principalement sur l'analyse de biomarqueurs en imagerie dans le but d'améliorer le diagnostic de RIS mais aussi dans l'objectif d'identifier des facteurs prédictifs d'évolution clinique des sujets RIS en SEP.

  • Comparison of individuals with radiologically isolated syndrome, early multiple sclerosis patients, and healthy controls using a digital neurological examination

    by Mikael Cohen, Lydiane Mondot, Xavier Ayrignac, Sandra Vukusic, Bertrand Bourre, Elisabeth Maillart, Hélène Zephir, Laure Michel, Eric Thouvenot, Parker Rice, et al.

    Background: The revised McDonald criteria shifted toward the recognition of the radiologically isolated syndrome (RIS) as the first phase of the multiple sclerosis (MS) spectrum. Objectives: To characterize differences between RIS individuals, early MS patients, and healthy controls (HCs) using a high-precision clinical assessment tool based on digital technology. Methods: We performed a multicentric, cross-sectional study involving RIS, early MS patients, and HC. Subjects were assessed using Neuraccure, an iPad application capable of detecting subtle abnormalities in four neurological functions: hand coordination, low-contrast vision, reaction time, and eye movements. Results: In total, 565 individuals were included (MS: 255, RIS: 146, HC: 164). HC performed better than RIS and MS across all digital measures ( p < 0.0001 to 0.03). There was no statistical difference between RIS and MS patients, except for the coordination test, which was slightly worse in MS patients ( p = 0.03). The receiver operating characteristic (ROC) analysis indicated that the presence of at least two impaired functions could detect RIS and MS from HC with 83.2% sensitivity and 84.3% specificity. A higher number of impaired functions were associated with lower brain magnetic resonance imaging (MRI) volumes. Conclusion: High-precision neurological evaluation can distinguish HC from RIS and MS at an individual scale with a good performance.


  • Analysis of healthcare utilization before the diagnosis of radiologically isolated syndrome

    by Christine Lebrun-Frenay, Sandrine Kerbrat, Darin T Okuda, Cassandre Landes-Chateau, Orhun H Kantarci, Chloe Pierret, Erwan Drezen, Emmanuel Nowak, Aksel Siva, Christina J Azevedo, et al.

    Background: Previous studies have shown that people with multiple sclerosis (MS) had frequent healthcare visits up to 10 years before being diagnosed but with no information from magnetic resonance imaging (MRI) scans of the connection with the radiologically isolated syndrome (RIS). Objective: To analyze healthcare use 3 years before the RIS diagnosis. Methods: We examined healthcare usage before the first scan in RIS cases from 2010 to 2019. RIS subjects were identified from the French National MS observatory and compared to the general population (matched 10:1) and MS patients (matched 4:1). Results: Among 482 RIS individuals, 223 (46.3%) were not linked to the healthcare resources database. The remaining RIS individuals (53.7%) had higher healthcare usage before their RIS diagnosis for issues related to neurology visits, headaches (odds ratio (OR): 3.34, confidence interval (CI): [2.00–5.57], p < 0.0001), and the use of anti-migraine drugs (OR: 2.61, CI: [1.37–4.99], p = 0.004) compared to MS. Conclusion: Only about half of RIS patients had MS-selected healthcare resources, which allowed for data linkage. Those who did seek care before their RIS diagnosis were most commonly known for other neurological comorbidities. These findings do not support the idea of a systemic prodrome before RIS diagnosis.


  • Choroid plexus enlargement correlates with periventricular pathology but not with disease activity in radiologically isolated syndrome

    by Cassandre Landes-Château, Vito Ag Ricigliano, Lydiane Mondot, Eric Thouvenot, Pierre Labauge, Céline Louapre, Hélène Zéphir, Françoise Durand-Dubief, Emmanuelle Le Page, Aksel Siva, et al.

    Background: Choroid plexus (ChP) enlargement is an emerging radiological biomarker in multiple sclerosis (MS). Objectives: This study aims to assess ChP volume in a large cohort of patients with radiologically isolated syndrome (RIS) versus healthy controls (HC) and explore its relationship with other brain volumes, disease activity, and biological markers. Methods: RIS individuals were included retrospectively and compared with HC. ChPs were automatically segmented using an in-house automated algorithm and manually corrected. Results: A total of 124 patients fulfilled the 2023 RIS criteria, and 55 HCs were included. We confirmed that ChPs are enlarged in RIS versus HC (mean (±SD) normalized ChP volume: 17.24 (±4.95) and 11.61 (±3.58), respectively, p < 0.001). Larger ChPs were associated with more periventricular lesions (ρ = 0.26; r2 = 0.27; p = 0.005 for the correlation with lesion volume, and ρ = 0.2; r2 = 0.21; p = 0.002 for the correlation with lesion number) and lower thalamic volume (ρ = −0.38; r2 = 0.44; p < 0.001), but not with lesions in other brain regions. Conversely, ChP volume did not correlate with biological markers. No significant difference in ChP volume was observed between subjects who presented or did not have a clinical event or between those with or without imaging disease activity. Conclusions: This study provides evidence that ChP volume is higher in RIS and is associated with measures reflecting periventricular pathology but does not correlate with biological, radiological, or clinical markers of disease activity.


  • Open Access

    The diagnostic value of the central vein sign in radiologically isolated syndrome

    by Cassandre Landes‐Chateau, Michael Levraut, Darin T. Okuda, Albert Themelin, Mikael Cohen, Orhun H. Kantarci, Aksel Siva, Daniel Pelletier, Lydiane Mondot, Christine Lebrun‐Frenay, et al.

    Objective: The radiologically isolated syndrome (RIS) represents the earliest detectable preclinical phase of multiple sclerosis (MS). Increasing evidence suggests that the central vein sign (CVS) enhances lesion specificity, allowing for greater MS diagnostic accuracy. This study evaluated the diagnostic performance of the CVS in RIS.Methods: Patients were prospectively recruited in a single tertiary center for MS care. Participants with RIS were included and compared to a control group of sex and age‐matched subjects. All participants underwent 3 Tesla magnetic resonance imaging, including postcontrast susceptibility‐based sequences, and the presence of CVS was analyzed. Sensitivity and specificity were assessed for different CVS lesion criteria, defined by proportions of lesions positive for CVS (CVS+) or by the absolute number of CVS+ lesions.Results: 180 participants (45 RIS, 45 MS, 90 non‐MS) were included, representing 5285 white matter lesions. Among them, 4608 were eligible for the CVS assessment (970 in RIS, 1378 in MS, and 2260 in non‐MS). According to independent ROC comparisons, the proportion of CVS+ lesions performed similarly in diagnosing RIS from non‐MS than MS from non‐MS (p = 0.837). When a 6‐lesion CVS+ threshold was applied, RIS lesions could be diagnosed with an accuracy of 87%. MS could be diagnosed with a sensitivity of 98% and a specificity of 83%. Adding OCBs or Kappa index to CVS biomarker increased the specificity to 100% for RIS diagnosis.Interpretation: This study shows evidence that CVS is an effective imaging biomarker in differentiating RIS from non‐MS, with similar performances to those in MS.


  • Identification of demyelinating lesions and application of McDonald criteria when confronted with white matter lesions on brain MRI

    by C. Landes-Chateau, M. Levraut, M. Cohen, M. Sicard, C. Papeix, F. Cotton, A. Balcerac, A. Themelin, L. Mondot, C. Lebrun-Frenay